Showing results (171-180 of 273) with videos related to

Sort By:
Pageof 28
International Ophthalmology|September 4, 2020
Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eyeEman Al-Sharif, Diego Strianese, Nada H AlMadhi, et al.
Cornea|July 30, 2019
Topography and Pachymetry Guided, Rapid Epi-on Corneal Cross-Linking for Keratoconus: 7-year Study ResultsCiro Caruso, Robert L Epstein, Pasquale Troiano, et al.
British Journal of Clinical Pharmacology|April 11, 2012
Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional studyMichele Rinaldi, Flavia Chiosi, Roberto dell'Omo, et al.
American Journal of Ophthalmology|September 15, 2004
Prevalence of factor XIII Val34Leu polymorphism in patients affected by spontaneous subconjunctival hemorrhageFrancesco Parmeggiani, Ciro Costagliola, Carlo Incorvaia, et al.
Retina (Philadelphia, Pa.)|November 26, 2009
Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration: a 12-month follow-up studyCiro Costagliola, Mary Romano, Michele Della Corte, et al.
The British Journal of Ophthalmology|March 15, 2015
Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisationCiro Costagliola, Francesco Semeraro, Roberto dell'Omo, et al.
Journal of Clinical Medicine|November 14, 2023
Glaucoma as a Tauopathy-Is It the Missing Piece in the Glaucoma Puzzle?Maria Laura Passaro, Francesco Matarazzo, Gianmarco Abbadessa, et al.
Biomed Research International|August 13, 2014
Heavy silicone oil and intraocular inflammationFrancesco Morescalchi, Ciro Costagliola, Sarah Duse, et al.
Journal of Clinical Medicine|June 24, 2022
Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle GlaucomaMariaelena Filippelli, Giuseppe Campagna, Nicola Ciampa, et al.
Mediators of Inflammation|September 28, 2010
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implicationsClaudio Campa, Ciro Costagliola, Carlo Incorvaia, et al.
Pageof 28